|
Directly observed collections. If a direct observation collection is required of the employee, the Company
<br />will ensure that the DOT requirements (i.e., direct observation by the same -sex collector, observation of body -
<br />to -bottle urination, and use of full turn -around observation) procedures are followed.
<br />4. PHMSA Inspection Protocol for Specimen Collection Sites
<br />Compliance. "PHMSA's Substance Abuse Program Comprehensive Audit and Inspection Protocol Form,
<br />Specimen Collection Sites,'Form No,:'3.1 7 (Revision`2)" provides a separate inspection protocol for Specimen
<br />Collection Sites, The Company provides this protocol to correspond with the detail found in the PHMSA Inspection
<br />Form. As previously stated, the Company will ensure that all DOT drug tests comply with Part 40 requirements.
<br />Collection Personnel, The Company will ensure that only qualified collectors are used to conduct Company
<br />DOT tests. An immediate supervisor of an employee may be used in cases where there are no qualified collectors
<br />available, and where their use is the only way to get the test conducted. Collectors will maintain documentation
<br />to verify they meet training requirements and will make that documentation available to the Company on request.
<br />If an error occurs causing a test to be cancelled and the error is directly attributed to the collector, the collector
<br />will undergo error -correction training within 30 days of the date of notification of the error that led to the need for
<br />training.
<br />Collection Sites, Forms and Supplies, The Company will use designated collection sites that meet DOT
<br />requirements. If the collection site uses a facility normally used for other purposes, the collector will ensure that it
<br />meets DOT standards before continuing the collection.
<br />Access to collection materials and specimens will be restricted, and the facility will be secured against access during
<br />the procedure to ensure privacy to the employee and prevent distraction of the collector. Limited -access signs
<br />will be posted as necessary. The collector will maintain personal control over each specimen and CCF throughout
<br />the collection process and will prevent unauthorized personnel from entering any party of the site in which urine
<br />specimens are collected or stored. The current CCF and a collection kit, that meets the requirements of Appendix
<br />A to Part 40, will be used for DOT collections.
<br />Specimen Collections. Collectors will explain the basic collection procedures to the employee, including showing
<br />the employee the instructions on the back of the CCF.In most all collections, the Company will provide the employee
<br />with a kit and CCF to carry to the, collection site. In other collections, collectors will provide the employee with an
<br />individually wrapped or sealed, collection container from the collection kit materials.
<br />Precautions will be taken to ensure that unadulterated specimens are obtained and correctly identified. Specimen
<br />integrity will be maintained by: bluing agents being added in the toilet tank and all water sources secured; positive
<br />photo identification of the employee for collection, notification of the DER if the employee fails to arrive at the
<br />assigned time; having the employee remove any unnecessary outer garments (purses or briefcases will remain with
<br />the outer.garments); having employees wash and dry their hands; and, to the greatest extent possible, the collector
<br />will keep an employee's collection container within view of both the collector and the employee between the time the
<br />employee has urinated and the specimen is sealed. Any unusual behavior will be noted on the CCF.
<br />Following the collection, the specimen will be checked for sufficient volume (i.e., 45 mL), acceptable temperature
<br />range (i.e., between 90-100 degrees F), and shows no signs of tampering (e.g., color, odor). Having problematic
<br />issues with specimen volume, the collector will follow DOT's "shy bladder" procedures; problems with temperature
<br />or tampering will result in the collector conducting a second collection under direct observation (see Section V.2,
<br />"Drug Tests That Require Direct Observation Procedures"). Direct observation procedures will be used for all
<br />collections where the reason -for -test is either return -to -duty or follow-up. Direct observation procedures will also
<br />be used for collections when a specimen is provided and the temperature is out of range, when the specimen
<br />appears to have been tampered with or when a previous specimen has been reported as invalid, adulterated,
<br />substituted or negative -dilute with a creatinine concentration greater than or equal to 2 mg/dL, but less than or
<br />equal to 5mg/dL, as defined in Part 40. If the collector does a monitored collection, same gender monitors will be
<br />used if the monitors are non -medical personnel.
<br />Premium Concrete Servlcas, Inc: PHMSA DRUG/ALCOHOL PLAN 23
<br />i'� IJ 1TIONAL COMI'LIAnC[ MAJIAGEMEMT SERVICE, INC. (NGMS) 2Ui I (ullVale 2U21�. il,e Nf.MS plan i,
<br />Ilse b'u�iecl al a regisleied capyli9l�t "nil Is proledoU I,y copYrl9hi lat•�s In Ilse U.S. an,l elsevvl,ero. All ngl,is
<br />esewed
<br />
|